Cannvalate

Cannvalate was established in early 2018 by medical professionals and leaders in the industry and quickly rose to become one of Australia's leading medicinal cannabis companies. With operations across Australia, New Zealand, and soon the UK, Cannvalate provides services across the breadth of the industry.

Cannvalate © is dedicated to improving the health and wellbeing of patients. This is achieved by streamlining patient access, bringing safe and effective cannabinoid-based products to the Australian market.
Australia’s first medicinal cannabis company that is supported and financed by the medical community. Australian Cannabis Market Access (ACMA)
This program is a turnkey solution allowing international and local licenced producers immediate and cost-effective access to the Australian Cannabis Market.